Enrollment change • Trial completion date • Trial termination • Trial primary completion date
|
HLA-A (Major Histocompatibility Complex, Class I, A) • PRAME (Preferentially Expressed Antigen In Melanoma)
|
HLA-A*02:01 • HLA-A*02 • PRAME expression • HLA-A2 positive
|
MDG1011